Cipla Executive and Leadership Team

Ashish Vig, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) at Cipla, directs the expansion of digital health initiatives and modern retail channels. Overseeing the integration of eCommerce platforms, Vig drives the modernization of pharmacy distribution networks to enhance consumer accessibility. This leadership role involves coordinating with cross-functional teams to scale digital health solutions across international markets. By optimizing organized retail pharmacy partnerships, Ashish Vig ensures the seamless delivery of branded generic medicines to diverse patient populations. The Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) also manages the strategic deployment of consumer healthcare products, focusing on digital transformation to capture emerging market opportunities. Through these efforts, Vig strengthens the company's position in the competitive landscape of modern pharmaceutical retail and digital health services.

Marc Falkin, the Chief Executive Officer (North America) at Cipla, directs all pharmaceutical operations and market growth strategies across the North American region. Overseeing the distribution of complex generic formulations and specialty medicines, Falkin ensures strict adherence to regulatory standards while expanding the company's footprint in the United States. This leadership role involves managing high-stakes relationships with healthcare providers and distributors to maintain a robust supply chain for critical care and respiratory products. By analyzing market trends and competitive dynamics, Marc Falkin optimizes the regional portfolio to address unmet medical needs in cardiovascular and oncology segments. The Chief Executive Officer (North America) also collaborates with global manufacturing teams to align production capacity with regional demand. Through these strategic initiatives, Falkin secures long-term revenue growth and reinforces the reputation of the company as a reliable provider of essential healthcare solutions in the North American market.

Satish Kadam, the Chief Financial Officer at Cipla, directs the global financial strategy, capital allocation, and fiscal reporting processes. Overseeing the financial health of the organization, Kadam ensures the efficient management of resources across the Pharmaceuticals and New Ventures segments. This leadership role involves coordinating with the Board to maintain transparency and drive sustainable profitability through rigorous cost control and investment analysis. By monitoring international market fluctuations, Satish Kadam mitigates financial risks associated with global operations in India, South Africa, and other regions. The Chief Financial Officer also supports the development of biosimilars and specialty medicine businesses by providing the necessary fiscal oversight for research and development projects. Through disciplined financial planning, Kadam enables the company to invest in innovative therapeutic areas while maintaining a strong balance sheet to support long-term growth objectives and shareholder value.

Sneha Hiranandani, the Chief Information Officer at Cipla, directs the enterprise-wide technology infrastructure and digital transformation initiatives. Overseeing the implementation of advanced data analytics and cybersecurity frameworks, Hiranandani ensures the integrity and security of pharmaceutical manufacturing and distribution systems. This leadership role involves aligning IT strategy with the company's global mission to provide accessible healthcare through digital innovation. By modernizing internal processes and supporting the integration of new ventures, Sneha Hiranandani drives operational efficiency across all therapeutic segments. The Chief Information Officer also manages the deployment of cloud-based solutions to facilitate real-time collaboration between international research teams and manufacturing facilities. Through these technological advancements, Hiranandani enables the company to respond rapidly to market demands and maintain a competitive edge in the global pharmaceutical industry, ensuring that data-driven insights inform every aspect of the business.

Kanchan Israni, the Chief Revenue Officer, Category Lead Outsourcing at Cipla, directs revenue growth strategies and manages the outsourcing of key pharmaceutical categories. Overseeing the commercial performance of diverse product lines, Israni ensures that market penetration targets are met across both generic and branded medicine portfolios. This leadership role involves architecting partnerships with external manufacturers and suppliers to optimize the supply chain for finished formulations. By focusing on category-specific growth, Kanchan Israni drives the expansion of the company's presence in infectious diseases and metabolic disorder markets. The Chief Revenue Officer, Category Lead Outsourcing also collaborates with regional sales teams to refine pricing strategies and improve market access. Through these efforts, Israni maximizes the profitability of the company's extensive product range, ensuring that outsourcing operations align with the broader corporate goal of delivering high-quality, affordable healthcare solutions to patients on a global scale.

Rohidas Patil, the Sr. Executive Chief Marketing Officer Operations At Cipla, directs the execution of global marketing campaigns and operational branding strategies. Overseeing the promotion of the company's extensive therapeutic portfolio, Patil ensures that marketing initiatives effectively communicate the value of respiratory, oncology, and critical care products to healthcare professionals. This leadership role involves coordinating with regional marketing teams to tailor messaging for diverse international markets, including India and South Africa. By leveraging market research and consumer insights, Rohidas Patil optimizes the positioning of branded generic medicines to drive brand loyalty and market share. The Sr. Executive Chief Marketing Officer Operations At Cipla also manages the operational aspects of product launches, ensuring that marketing activities are synchronized with supply chain availability. Through these strategic efforts, Patil enhances the visibility of the company's healthcare solutions and supports the overall growth of the business.

Prabir Jha, the Chief People Officer at Cipla, directs the global human resources strategy, talent acquisition, and organizational development initiatives. Overseeing the cultivation of a high-performance culture, Jha ensures that the company attracts and retains top-tier talent to support its mission in the pharmaceutical sector. This leadership role involves designing comprehensive training programs and leadership development frameworks that align with the company's long-term growth objectives. By fostering an inclusive and innovative work environment, Prabir Jha drives employee engagement across international operations, including the diverse teams in India and abroad. The Chief People Officer also manages performance management systems and compensation structures to incentivize excellence in research, manufacturing, and commercial functions. Through these human capital strategies, Jha strengthens the organizational foundation, enabling the company to adapt to the evolving needs of the global healthcare market while maintaining a focus on employee well-being and professional growth.